Humacyte HUMA
NASDAQ HUMA
$0.59 +0.00 (+0.29%)
At close: Nov 11, 2026 · 4:00 PM EST

Humacyte (HUMA) Shares Repurchased (2020 - 2021)

Updated

Analysis

Humacyte (HUMA) Shares Repurchased (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 370.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Humacyte 163.90 Mn -213.24 Mn -401,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 18.92 Mn
Mar 31, 2021 -9.60 Mn
Sep 30, 2020 16.02 Mn
API Access

Humacyte Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=HUMA&period=max&api_key=YOUR_API_KEY